Polymorphisms of the HSD17B6 and HSD17B5 genes in chinese women with polycystic ovary syndrome

Journal of Women's Health

Volumn 19, Issue 12, 2010, Pages 2227-2232

  Ke, Lu ^a   Che, Ye Na ^a   Cao, Yun Xia ^b   Wu, Xiao Ke ^c   Hu, Ya Li ^b   Sun, Hai Xiang ^a   Liang, Feng Jing ^a   Sun, Jing ^a   Yi, Long ^a   Wang, Yong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 5; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 6; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

3-HYDROXYSTEROID DEHYDROGENASES; ADULT; CHINA; CONTROL GROUPS; FEMALE; GENETIC MARKERS; GENETIC TESTING; GONADOTROPINS, PITUITARY; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; MENARCHE; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RACEMASES AND EPIMERASES; TESTOSTERONE;

EID: 78649679490     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1902     Document Type: Article

References (23)

1. Matalliotakis I, Kourtis A, Panidis D. Polycystic ovary syndrome: Etiology and pathogenesis. Arch Gynecol Obstet 2006;274:187-197.
2. Zhang L. Clinical reproductive endocrinology. Beijing: Chinese Scientific Press, 2001.
3. Chang W, Knochenhauer E, Bartolucci A, et al. Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005;83:1717-1723.
4. Gilling SC, Willis DS, Beard RW, et al. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 1994;79:1158-1165.
5. Legro R, Spielman R, Urbanek M, et al. Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res 1998;53:217-256.
6. Evanthia DK, Christina P. Genetics of polycystic ovary syndrome: Searching for the way out of the labyrinth. Hum Reprod Update 2005;11:631-643.
7. Gaasenbeek M, Powell B, Sovio U, et al. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 2004;89:2408-2413.
8. Jin L, Zhu XM, Luo Q, Qian Y, Jin F, Huang HF. A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS. Mol Hum Reprod 2006;12:151-155.
9. Michelle R, Lisa I, Scott G, et al. Polymorphism in 17/?-HSD6 is associated with key features of polycystic ovary syndrome. Fertil Steril 2006;86:1438-1446.
10. Christopoulos P, Mastorakos G, Gazouli M, et al. Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:486-490.
11. Mendonca B, Arnhold I, Bloise W, et al. 17/-Hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999;84:802-804.
12. Simoni M, Tempfer C, Destenaves B, et al. Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008;14:459-484.
13. Kenan Q, David A, Nancy C, et al. Identification of a functional polymorphism of the human type 5 17/-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:270-276.
14. Goodarzi M, Jones M, Antoine H, et al. Nonreplication of the type 5 17/?-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:300-303.
15. Petry CJ, Ong KK, Wingate DL, et al. Lack of association between common polymorphism in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche. J Steroid Biochem Mol Biol 2007;105: 176-180.
16. Marioli D, Saltamavros A, Vervita V, et al. Association of the 17/?-hydroxysteroid dehydrogenase type 5 gene polymorphism (\71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS). Fertil Steril 2009;92: 648-652.
17. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
18. Jin JL, Sun J, Ge HJ, et al. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC Med Genet 2009; 10:139.
19. Deng GR. A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer. Nucleic Acids Res 1988; 16:6231.
20. Zawadzki J, Dunaif A, Givens J, et al. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. Boston, MA: Blackwell Scientific, 1992.
21. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrin Metab 2006;91:781-785.
22. Jones MR, Mathur R, Cui J, et al. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydro-xysteroid dehydrogenase gene. J Clin Endocrinol Metab 2009;94:5034-5038.
23. Napoli J. 17b-Hydroxysteroid dehydrogenase type 9 and other short chain dehydrogenases=reductases that catalyze retinoid, 17b-and 3a-hydroxysteroid metabolism. Mol Cell Endocrinol 2001;171:103-109.